[1]
“Treat to Target ASCVD Risk with Oral Non-statins and Bempedoic Acid: DELPHI Statement”, ccm, vol. 7, no. 4, pp. 265–272, Jul. 2023, Accessed: Sep. 17, 2026. Available: https://fortunejournals.org/ojs/index.php/ccm/article/view/16422